Vascular Dementia Market Expansion Outlook: $5.07 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Vascular Dementia Market By 2029?

The vascular dementia market size has experienced significant expansion in recent years. This market is set to expand from $2.92 billion in 2024 to $3.27 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.8%. Historically, this growth can be attributed to increasing healthcare expenditure, a rise in the number of patients diagnosed with vascular dementia, an increase in healthcare professionals, the growth in public health initiatives, and a rise in the prevalence of diabetes.

The vascular dementia market size is projected to experience swift expansion over the coming years. It is expected to reach $5.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.6%. This anticipated growth during the forecast period can be attributed to factors such as increasing awareness of vascular dementia, a rise in healthcare investments, a burgeoning aging population, the growing prevalence of cardiovascular diseases, and the rising incidence of high blood pressure. Significant trends within this forecast period include technological advancements, the adoption of personalized care plans, the expansion of telemedicine, developments in gene therapy, and the integration of artificial intelligence.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

Which Factors And Drivers Are Influencing The Vascular Dementia Market In 2025?

The increasing occurrence of cardiovascular disease is anticipated to boost the vascular dementia market in the future. Cardiovascular diseases encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and hypertension. This growing prevalence of cardiovascular conditions stems from factors like unhealthy lifestyles, inadequate dietary choices, lack of physical activity, elevated stress, an aging populace, and an increase in risk factors including obesity, diabetes, and hypertension. Cardiovascular disease heightens the likelihood of vascular dementia by hindering blood supply to the brain, resulting in cognitive impairment and harm to brain cells from insufficient oxygen and nutrients. For example, data released in September 2024 by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that in the UK, about 7.6 million individuals suffer from heart and circulatory diseases, comprising approximately 4 million males and 3.6 million females. These illnesses contribute to roughly 27% of all fatalities in the UK, amounting to over 170,000 deaths yearly, or about 480 deaths daily, which signifies one death every three minutes. Consequently, the increasing occurrence of cardiovascular diseases propels the vascular dementia market.

How Is The Vascular Dementia Market Segmented?

The vascular dementiamarket covered in this report is segmented –

1) By Product: Monoclonal Antibodies; Small Molecules; Peptides

2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

3) By End User: Hospitals And Clinics; Rehabilitation Centers; Specialty Clinics

Subsegments:

1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies; Anti-Tau Monoclonal Antibodies

2) By Small Molecules: Cholinesterase Inhibitors; Glutamate Modulators; Anti-Inflammatory Small Molecules

3) By Peptides: Amyloid-Beta Targeted Peptides; Neuroprotective Peptides; Tau-Targeting Peptides

How Are Trends Influencing The Vascular Dementia Market?

Key companies operating in the vascular dementia market are concentrating on developing innovative therapies, particularly multimodal approaches, to maintain their standing. Multimodal therapies involve integrating various treatment methods, such as medications, physical therapy, and psychological interventions, to address a condition thoroughly. For instance, in January 2023, Moleac, a Singapore-based biopharmaceutical company, launched CognivAiD, an evidence-based treatment specifically formulated for vascular dementia (VaD), a condition with limited therapeutic choices. This product combines active extracts from ginkgo, ginseng, and saffron, which have been shown to significantly slow cognitive decline in VaD patients. CognivAiD’s unique multimodal action targets crucial mechanisms of vascular dementia, including vascular protection, vasoregulation, and neuroinflammation. Backed by extensive clinical trials and a strong safety profile, CognivAiD presents a promising new treatment for individuals suffering from VaD.

Which Major Industry Participants Are Leading The Vascular Dementia Market Growth?

Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam’s Group of Hospitals, Alpha Cognition Inc., Citi Health

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

Which Geographies Are Emerging As Strong Markets For The Vascular Dementia Industry?

North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Vascular Dementia Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20998&type=smp

Browse Through More Reports Similar to the Global Vascular Dementia Market 2025, By The Business Research Company

Lewy Body Dementia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Anti Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Vascular Embolization Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795